Effi cacy of splenectomy in primary immune thrombocytopenia
Open Access
- 25 October 2021
- journal article
- research article
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 66 (3) , 362-373-373
Abstract
Introduction. Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. Splenectomy is one the most effective treatment methods for this disorder.Aim — to evaluate the effi cacy and safety of a splenectomy in patients with primary immune thrombocytopenia.Subjects and methods. 111 patients (31 males, 80 females) with primary immune thrombocytopenia who were hospitalized to perform laparoscopic splenectomy were included in a prospective study conducted at the National Research Center for Hematology from 2015 to 2019. Disease duration from onset to splenectomy was from 1 month to 51 years. Response to the splenectomy, complications, and correlation with immediate preoperative platelet count were analyzed.Results. Complete response was achieved in 79 (71.2 %) cases, a partial response was achieved in 11 (9.9 %) cases, and in 21 (18.9 %) cases there was no response. Immediate preoperative platelet count was signifi cantly higher in patients with complete response in comparison with the group with no response, median (95% CI): 47 (35–58) vs 16 (9–20), p < 0.001.Multivariate analysis (logistic regression) was performed. According to this regression, a risk factor for an unfavorable response was detected — males > 60 years of age, p = 0.05; RR (95% CI): 2.0 (0.9–7.1). A predictor of unfavorable response was identifi ed – immediate preoperative platelet count < 23 × 109/l (cutoff point determined in ROC-analysis); p = 0.001, RR (95% CI): 2.5 (1.1–8.6). The probability of complete response was lower with the number of treatment lines prior to splenectomy (weak inverse correlation: r S = −0.30; p = 0.01). The frequency of postoperative complications was 12.6 %. According to our follow-up data, a complete response was preserved in 66/79 (83.5 %) of patients, with a follow-up of 2.7 years.Conclusion. Splenectomy is an effective and safe treatment method for ITP. Factors of unfavorable response were identifi ed: males > 60 years of age and immediate preoperative platelet count < 23 × 109/l. It is safe to perform splenectomy regardless of effectiveness of preoperative splenectomy treatment and platelet count.Keywords
This publication has 38 references indexed in Scilit:
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopeniaBlood, 2013
- Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 yearsHaematologica, 2012
- Patient-reported treatment burden of chronic immune thrombocytopenia therapiesBMC Hematology, 2012
- Accessory splenectomy for refractory immune thrombocytopenic purpuraAmerican Journal of Hematology, 2011
- Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10‐year nationwide cohort studyJournal of Thrombosis and Haemostasis, 2010
- Epidemiology of paediatric immune thrombocytopenia in the General Practice Research DatabaseBritish Journal of Haematology, 2010
- Epidemiology of immune thrombocytopenic purpura in the General Practice Research DatabaseBritish Journal of Haematology, 2009
- Splenectomy for immune thrombocytopenic purpura: Surgery for the 21st centuryAmerican Journal of Hematology, 2007
- Analysis of outcome of laparoscopic splenectomy for idiopathic thrombocytopenic purpura by platelet countAmerican Journal of Hematology, 2005
- Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpuraSurgical Endoscopy, 2001